Company Profiles

driven by the PitchBook Platform

Alcresta Therapeutics

Description

Developer of enzyme-based nutritional products to manage disease for infants, older adults and patients battling acute or chronic conditions. The company offers a line of products with an added microbial enzyme that helps in breaking down complex foods so patients can easily digest them.

2011

Founded

PRIVATE

Status

11-50

Employees

Series C

Latest Deal Type

$50.9M

Latest Deal Amount

$70.9M

Total Amount Raised

Description

Developer of enzyme-based nutritional products to manage disease for infants, older adults and patients battling acute or chronic conditions. The company offers a line of products with an added microbial enzyme that helps in breaking down complex foods so patients can easily digest them.

Website:

www.alcresta.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Primary Office

One Newton Executive Park Suite 100 Newton, MA 02462United States +1 (617) 431-3600
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Alcresta Therapeutics's full profile, request a free trial.

Alcresta Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Alcresta Therapeutics Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Alcresta Therapeutics Investors (4)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Athyrium Capital ManagementAsset ManagerMinority000 0000000 0000
Bessemer Venture PartnersVenture CapitalMinority000 0000000 0000
Frazier Healthcare PartnersGrowth/ExpansionMinority000 0000000 0000
Third Rock VenturesVenture CapitalMinority000 0000000 0000
Athyrium Capital Management Asset Manager
Bessemer Venture Partners Venture Capital
Frazier Healthcare Partners Growth/Expansion
Third Rock Ventures Venture Capital

Alcresta Therapeutics Executive Team (11)

NameTitleBoard
Seat
Contact
Info
Karen SullivanDirector, Marketing
Kenneth GaryVice President, Product Operations
Steven ParsonsVice President, Sales & Market Access
Daniel TasséChairman & Chief Executive Officer
Robert GallottoCo-Founder & President
Karen Sullivan Director, Marketing
Kenneth Gary Vice President, Product Operations
Steven Parsons Vice President, Sales & Market Access
Daniel Tassé Chairman & Chief Executive Officer
Robert Gallotto Co-Founder & President

Alcresta Therapeutics Board Members (6)

NameRepresentingRoleSinceContact
Info
Alexey Margolin Ph.DSelfCo-Founder & Board Member000 0000
Daniel TasséAlcresta TherapeuticsChairman & Chief Executive Officer000 0000
James Topper Ph.DFrazier Healthcare PartnersManaging General Partner, Life Sciences000 0000
Jeremy Lack Ph.DAthyrium Capital ManagementPartner000 0000
Stephen KrausBessemer Venture PartnersPartner000 0000
Alexey Margolin Ph.D Co-Founder & Board Member Self
Daniel Tassé Chairman & Chief Executive Officer Alcresta Therapeutics
James Topper Ph.D Managing General Partner, Life Sciences Frazier Healthcare Partners
Jeremy Lack Ph.D Partner Athyrium Capital Management
Stephen Kraus Partner Bessemer Venture Partners
Request full access to PitchBook